MedPath

Hyaluronic Acid Filler IMD1 Basic for Correction of Nasolabial Folds

Phase 4
Completed
Conditions
Nasolabial Folds
Registration Number
NCT00429520
Lead Sponsor
Merz Pharmaceuticals GmbH
Brief Summary

Volunteers receive one injection IMD1 basic of correction of nasolabial folds and are followed-up for up to 36 weeks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria
  • main inclusion criteria: severity rating scale grade 3 or 4
Read More
Exclusion Criteria
  • main exclusion criterion: other nasolabial fold corrections within 6 months prior to study entry
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Severity rating scale assessed by independent rater
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Merz Pharmaceuticals

🇩🇪

Frankfurt, Germany

© Copyright 2025. All Rights Reserved by MedPath